Allakos plunges 75% on phase 1 data for urticaria asset
Allakos (NASDAQ:ALLK) has dropped ~75% in premarket trading Monday after posting disappointing phase 1 results on AK006 for chronic spontaneous urticaria and deciding to end development. Due to ...
Hosted on MSN2m
Triplex vaccine enters Phase 2 trial in stem cell donors
has completed Phase 1 and Phase 2 studies, demonstrating tolerability and high immunogenicity. It is currently the subject of multiple ongoing clinical trials across various transplant and HIV-1 ...
Israel says Hamas list shows 8 of 33 hostages to be freed in first phase of Gaza ceasefire are dead
Israel says a Hamas list shows that eight of the 33 hostages to be released in the first phase of the Gaza ceasefire are ...
BioSpace53m
Veru’s Drug Spares Lean Mass in Overweight, Obese Adults on Wegovy
Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were takin Wegovy ...